Effective repair of articular cartilage using human pluripotent stem cell-derived tissue.

In an effort to develop an effective source of clinically relevant cells and tissues for cartilage repair a directed differentiation method was used to generate articular chondrocytes and cartilage tissues from human embryonic stem cells (hESCs). It has previously been demonstrated that chondrocytes derived from hESCs retain a stable cartilage-forming phenotype following subcutaneous implantation in mice. In this report, the potential of hESC-derived articular-like cartilage to repair osteochondral defects created in the rat trochlea was evaluated. Articular cartilage-like tissues were generated from hESCs and implanted into the defects. After 6 and 12 weeks, the defects were evaluated histologically and immunohistochemically, and the quality of repair was assessed using a modified ICRS II scoring system. Following 6 and 12 weeks after implantation, hESC-derived cartilage tissues maintained their proteoglycan and type II collagen-rich matrix and scored significantly higher than control defects, which had been filled with fibrin glue alone. Implants were found to be well integrated with native host tissue at the basal and lateral surfaces, although implanted human cells and host cells remained regionally separated. A subset of implants underwent a process of remodeling similar to endochondral ossification, suggesting the potential for a single cartilaginous implant to promote the generation of new subchondral bone in addition to repair of the articular cartilage. The ability to create cartilage tissues with integrative and reparative properties from an unlimited and robust cell source represents a significant advance for cartilage repair that can be further developed in large animal models before clinical- setting application.

3'Sulfogalactolipid binding specifically inhibits Hsp70 ATPase activity in vitro.

A method for the generation of soluble glycosphingolipid derivatives that retain the receptor activity of the parent (BBRC 257:391-394, Carb Res 335:91-100) was used to investigate the consequence of 3'sulfogalactolipid (SGL) specific binding within the N-terminal ATPase-containing domain of Hsc70. Sulfogalactosyl ceramide (SGC) was deacylated, and the resulting sulfogalactosylsphingosine coupled to an alpha-adamantane or a norbornane rigid hydrophobic frame. The resulting conjugate preferentially partitioned into water, as opposed to organic solvent. In the range of 100-300 microM, these conjugates inhibited the specific binding of bovine brain Hsc70 to immobilized SGLs. A similar dose-related inhibition of bovine brain Hsc70 ATPase activity was seen between 100 and 300 microM adamantylSGC (adaSGC). Adamantyl conjugates of glycolipids not bound by Hsp70s had no effect. Kinetic analysis indicated that adaSGC was a noncompetitive inhibitor of Hsc70 ATPase activity, a special case of mixed inhibition since the K(m) values were not statistically different, 0.89 +/- 0.024 microM to 0.93 +/- 0.038 microM, but the V(max) decreased from 0.20 +/- 0.012 pmol min(-1) microg(-1) to 0.15 +/- 0.016 pmol min(-1) microg(-1). A reproducible 5 min lag was observed prior to ATPase inhibition that could be eliminated by preincubation of adaSGC with Hsc70 or by adding the cochaperone Hdj-1. The dependence of ATPase inhibition on the rate of hydrolysis indicates that adaSGC binding occurs at a specific stage of the ATPase cycle. These studies identify a new mechanism for the regulation of Hsp70 ATPase activity.

Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by recombinant prokaryotic and eukaryotic hsp70 family members.

Specific 3'-sulfogalactolipid [SGL-sulfogalactosyl ceramide (SGCer) and sulfogalactosylglycerolipid (SGG)] binding is compared for hsp70s cloned from Helicobacter pylori, Haemophilus influenzae, Chlamydia trachomatis serovar E, Escherichia coli, murine male germ cells, and the hsp70-like extracellular domain within the sperm receptor from Strongylocentrotus purpuratus. This lectin activity, conserved among the different hsp70 family members, is modulated by the SGL aglycone. This is shown by differential binding to both SGC fatty acid homologues and 3'-sulfogalactolipid neoglycoproteins generated by coupling bovine serum albumin (BSA) and glycosyl ceramide acids synthesized by oxidation of the double bond of sphingosine. Eukaryotic hsp70s preferentially bound the SGCer fatty acid homologues SG(24)Cer, SG(18)Cer, and SG(20:OH)Cer, while prokaryotic hsp70s bound SG(18:1)Cer and SG(20:OH)Cer. Eukaryotic hsp70s bound SGCer-BSA and SG(24)Cer-BSA conjugates where the latter is the main constituent in SGCer-BSA, while prokaryotic hsp70s bound SG(20:OH)Cer-BSA. None of the hsp70s bound sulfogalactosyl sphingosine (SGSph) or SGSph-BSA, further demonstrating the important role of the aglycone. Although the primary SGL recognition domain of all hsp70s is conserved, we propose that aglycone organization differentially influences the interaction with the sub-site. Heterogeneous SGCer aglycone isoforms in cells and the differential in vitro binding of eukaryotic and prokaryotic hsp70s may relate to their different adhesin roles in vivo as mediators of germ cell and bacterial/host interactions, respectively.

Abomasal pH, nutrient digestibility, and growth of Holstein bull calves fed acidified milk replacer.

Our objective was to compare nutrient digestion and utilization, amount and pattern of intake, and pH profile over time of abomasal contents in calves offered acidified milk replacer ad libitum or regular (sweet) milk replacer twice daily at 10% of body weight per day. Ten Holstein bull calves were fed replacers reconstituted to 13% dry matter for 4 wk. Daily milk replacer and water consumption and weekly body weight were recorded. Other variables were measured during the 2nd and 4th wk. Calves offered acidified replacer consumed more dry matter and gained more body weight than did calves fed sweet replacer; however, there was no difference in feed conversion ratio. Apparent digestibility of dry matter, ether extract, nitrogen, and retention of absorbed nitrogen were not affected by treatment. Acidified milk replacer offered ad libitum lowered the pH of abomasal contents and feces compared to regular replacer offered at 10% of body weight per day. Feeding patterns of calves offered acidified replacer ad libitum were variable. No adverse effects of feeding acidified milk replacer were noted.

Identification and characterization of a fatty acid binding protein in bovine mammary gland.

A fatty acid binding protein (FABP) was isolated from bovine mammary cytosol by gel filtration and ion exchange chromatography. Polyacrylamide gel electrophoresis in sodium dodecyl sulfate indicated a mol. wt. of 12,000. Isoelectric focusing showed two bands at pH 5.6 and 5.8. FABP bound long chain fatty acids and their CoA thioesters, but not medium or short chain fatty acids. Affinity constant (Ka) for 18:1 was about 2 micromolar. Endogenously bound fatty acids included 16:0, 18:0 and 18:1, in both covalent and noncovalent association with FABP. Activities of microsomal phosphatidic acid phosphatase, fatty acid:CoA ligase or diacylglycerol acyltransferase were not affected by purified FABP in vitro.

Effect of source and particle size of supplemental phosphate on rumen function of steers fed high concentrate diets.

We examined effects of source and particle size of supplemental defluorinated rock phosphate, to meet phosphorus requirements, on rumen function of 195-kg Holstein steers fed high concentrate. Two sources and two particle sizes of each source were evaluated in a 5 X 5 Latin square with 14-day periods. There was no effect of source on ruminal mH [- log (mean (H+)]; however, ruminal mH was higher in animals fed supplements of larger particle size. This effect was also evident when rumen pH versus time curves were integrated below pH 6. Animals fed supplements of larger particle size had less area below pH 6 than those fed supplements of smaller size. Ruminal buffering capacity at pH 7 was affected by diet; however, orthogonal comparisons between treatment means were not significant. Neither source nor particle size of the supplement affected ruminal fluid osmolality, total volatile fatty acid concentration, or fecal starch. Water intake and ruminal dry matter on HyCal supplemented diets; however, there was also a trend toward increasing rumen fluid volume. The net effect was little change of dilution rate of ruminal fluid. This may explain why rumen fermentation was not affected greatly. Conventional phosphate supplements may have potential as rumen buffering agents, but higher levels of feeding should be studied.

Effect of monensin on breakdown of protein by ruminal microorganisms in vitro.

The effects of monensin on N metabolism by ruminal microorganisms in a semicontinuous culture system were determined. Rumen fluid inoculum was obtained from steers fed a hay-concentrate diet (60:40 ratio on a dry matter basis) containing 33 ppm monensin. Treatments were 0, 1 and 4 mg monensin/kg of incubation mixture, with starch, glucose, cellulose and casein used as the energy and protein sources. Casein degradation decreased linearly (P less than .01) with increasing levels of monensin, as did production of ammonia-N (P less than .05) and microbial N (P less than .01). Increases were observed in nonammonia, nonmicrobial N (P less than .01), alpha-amino N (P less than .10) an total peptides (P less than .001). The culture supernatant was fractionated on a Sephadex G-10 column to separate peptides. With the 4 mg/kg treatment, the percentage of the total ninhydrin positive material eluted at an elution volume:void volume ratio of 1.5 or less was greater than the percentage eluted with the 0 or 1 mg/kg treatments (P less than .025). Acetate production and molar proportion decreased (P less than .001), while propionate production was unchanged. Methane production decreased slightly (P less than .10). Cellulose degradation was markedly inhibited (P less than .001) by monensin treatment.